4 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and in Vitro Anticancer Activity of the First Class of Dual Inhibitors of REV-ERBß and Autophagy.

Fondazione Istituto Italiano Di Tecnologia
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.

The Scripps Research Institute